Corrigendum to “Inhibitory effects of wogonin on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9” [Toxicology 282 (2011) 122–128](S0300483X11000370)(10.1016/j.tox.2011.01.018);Inhibitory effects of wogonin on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9

Toxicology

Volumn 282, Issue 3, 2011, Pages 122-128

  Chen, Pu ^a   Lu, Na ^a   Ling, Yun ^a   Chen, Yan ^a   Hui, Hui ^a   Lu, Zhijian ^a   Song, Xiuming ^a   Li, Zhiyu ^a   You, Qidong ^a   Guo, Qinglong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

ERK1 2; Invasion; MMP 9; PKC ; Wogonin

Indexed keywords

GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; WOGONIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CARCINOMA CELL; DOWN REGULATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSLOCATION LINE;

SCUTELLARIA RADIX;

EID: 79952312969     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2019.152288     Document Type: Erratum

References (32)

1. Bachmeier B.E., Iancu C.M., Jochum M., Nerlich A.G. Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach. Expert Rev. Anticancer Ther. 2005, 5:149-163.
2. Batarseh A., Giatzakis C., Papadopoulos V. Phorbol-12-myristate 13-acetate acting through protein kinase Cepsilon induces translocator protein (18-kDa) TSPO gene expression. Biochemistry 2008, 47:12886-12899.
3. Chakraborti S., Mandal M., Das S., Mandal A., Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol. Cell. Biochem. 2003, 253:269-285.
4. Chi Y.S., Cheon B.S., Kim H.P. Effect of wogonin, a plant flavone from Scutellaria radix, on the suppression of cyclooxygenase-2 and the induction of inducible nitric oxide synthase in lipopolysaccharide-treated RAW 264.7 cells. Biochem. Pharmacol. 2001, 61:1195-1203.
5. Cho H.J., Kang J.H., Kwak J.Y., Lee T.S., Lee I.S., Park N.G., Nakajima H., Magae J., Chang Y.C. Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms. Carcinogenesis 2007, 28:1104-1110.
6. Duffy M.J., Maguire T.M., Hill A., McDermott E., O'Higgins N. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res. 2000, 2:252-257.
7. Fahrmann M., Kaufhold M., Rieg T., Seidler U. Different actions of protein kinase C isoforms alpha and epsilon on gastric acid secretion. Br. J. Pharmacol. 2002, 136:938-946.
8. Fishman D.A., Liu Y., Ellerbroek S.M., Stack M.S. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. Cancer Res. 2001, 61:3194-3199.
9. Ghajar C.M., George S.C., Putnam A.J. Matrix metalloproteinase control of capillary morphogenesis. Crit. Rev. Eukaryot. Gene Expr. 2008, 18:251-278.
10. Hui K.M., Huen M.S., Wang H.Y., Zheng H., Sigel E., Baur R., Ren H., Li Z.W., Wong J.T., Xue H. Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi. Biochem. Pharmacol. 2002, 64:1415-1424.
11. Ko C.H., Shen S.C., Lee T.J., Chen Y.C. Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Mol. Cancer Ther. 2005, 4:281-290.
12. Libra M., Scalisi A., Vella N., Clementi S., Sorio R., Stivala F., Spandidos D.A., Mazzarino C. Uterine cervical carcinoma: role of matrix metalloproteinases (review). Int. J. Oncol. 2009, 34:897-903.
13. Lim B.O. Effects of wogonin, wogonoside, and 3,5,7,2',6'-pentahydroxyflavone on chemical mediator production in peritoneal exduate cells and immunoglobulin E of rat mesenteric lymph node lymphocytes. J. Ethnopharmacol. 2003, 84:23-29.
14. Lin C.W., Hou W.C., Shen S.C., Juan S.H., Ko C.H., Wang L.M., Chen Y.C. Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 2008, 29:1807-1815.
15. Lu N., Gao Y., Ling Y., Chen Y., Yang Y., Gu H.Y., Qi Q., Liu W., Wang X.T., You Q.D., Guo Q.L. Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2. Life Sci. 2008, 82:956-963.
16. Price J.T., Thompson E.W. Mechanisms of tumour invasion and metastasis: emerging targets for therapy. Expert Opin. Ther. Targets 2002, 6:217-233.
17. Qi Q., Gu H., Yang Y., Lu N., Zhao J., Liu W., Ling H., You Q.D., Wang X., Guo Q. Involvement of matrix metalloproteinase 2 and 9 in gambogic acid induced suppression of MDA-MB-435 human breast carcinoma cell lung metastasis. J. Mol. Med. 2008, 86:1367-1377.
18. Roach D.M., Fitridge R.A., Laws P.E., Millard S.H., Varelias A., Cowled P.A. Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline. Eur. J. Vasc. Endovasc. Surg. 2002, 23:260-269.
19. Rosenblum G., Meroueh S.O., Kleifeld O., Brown S., Singson S.P., Fridman R., Mobashery S., Sagi I. Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2). J. Biol. Chem. 2003, 278:27009-27015.
20. Roskelley C.D., Williams D.E., McHardy L.M., Leong K.G., Troussard A., Karsan A., Andersen R.J., Dedhar S., Roberge M. Inhibition of tumor cell invasion and angiogenesis by motuporamines. Cancer Res. 2001, 61:6788-6794.
21. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994, 370:61-65.
22. Shen S.C., Lin C.W., Lee H.M., Chien L.L., Chen Y.C. Lipopolysaccharide plus 12-o-tetradecanoylphorbol 13-acetate induction of migration and invasion of glioma cells in vitro and in vivo: differential inhibitory effects of flavonoids. Neuroscience 2006, 140:477-489.
23. Srivastava A.K., Qin X., Wedhas N., Arnush M., Linkhart T.A., Chadwick R.B., Kumar A. Tumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathway. J. Biol. Chem. 2007, 282:35113-35124.
24. Tai M.C., Tsang S.Y., Chang L.Y., Xue H. Therapeutic potential of wogonin: a naturally occurring flavonoid. CNS Drug Rev. 2005, 11:141-150.
25. Virtanen S.S., Vaananen H.K., Harkonen P.L., Lakkakorpi P.T. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res. 2002, 62:2708-2714.
26. Wang W., Guo Q., You Q., Zhang K., Yang Y., Yu J., Liu W., Zhao L., Gu H., Hu Y., Tan Z., Wang X. Involvement of bax/bcl-2 in wogonin-induced apoptosis of human hepatoma cell line SMMC-7721. Anticancer Drugs 2006, 17:797-805.
27. Westermarck J., Holmstrom T., Ahonen M., Eriksson J.E., Kahari V.M. Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38. Matrix Biol. 1998, 17:547-557.
28. Woo J.H., Lim J.H., Kim Y.H., Suh S.I., Min D.S., Chang J.S., Lee Y.H., Park J.W., Kwon T.K. Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene 2004, 23:1845-1853.
29. Xie Z., Singh M., Singh K. Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1beta. J. Biol. Chem. 2004, 279:39513-39519.
30. Yan C., Boyd D.D. Regulation of matrix metalloproteinase gene expression. J. Cell. Physiol. 2007, 211:19-26.
31. Yoon S.O., Shin S., Lee H.J., Chun H.K., Chung A.S. Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase/Akt-dependent matrix metalloproteinase-9 expression. Mol. Cancer Ther. 2006, 5:2666-2675.
32. Zhang J., Anastasiadis P.Z., Liu Y., Thompson E.A., Fields A.P. Protein kinase C (PKC) betaII induces cell invasion through a Ras/Mek-, PKC iota/Rac 1-dependent signaling pathway. J. Biol. Chem. 2004, 279:22118-22123.